(Q42148878)

17 October 2017

Osteosarcoma: evolution of treatment paradigms (English)

1 reference

17 October 2017

Norman Jaffe

1

1 reference

17 October 2017

Ajay Puri

series ordinal

2

1 reference

17 October 2017

Hans Gelderblom

series ordinal

3

1 reference

17 October 2017

27 May 2013

1 reference

17 October 2017

1 reference

17 October 2017

2013

1 reference

17 October 2017

203531

1 reference

Creative Commons Attribution 3.0 Unported

17 October 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Computer-assisted tumor surgery in malignant bone tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

A meta-analysis of osteosarcoma outcomes in the modern medical era

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Methotrexate for high-grade osteosarcoma in children and young adults

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

29 May 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

The therapy of osteogenic sarcoma: Current status and thoughts for the future

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Vaccine trials for osteogenic sarcoma. A preliminary report

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Trends and variability in survival among patients with osteosarcoma: a 7-year update

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Study of Adjuvant Chemotherapy in Osteogenic Sarcoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. A Southwest Oncology Group study

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Dialyzable transfer factor in the treatment of human osteosarcoma: an analytic review

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Cis-diamminedichloroplatinum (NSC-119875) in childhood malignancies: A southwest oncology group study

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Intraoperative microwave inactivation in-situ of malignant tumors in the scapula.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

Effect of delayed administration of citrovorum factor on the antileukemic effectiveness of aminopterin in mice

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678494

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

3 November 2018

1 reference

12 December 2020

Adoptive immunotherapy in primary osteosarcoma. An interim report

1 reference

12 December 2020

The concept of curative margin in surgery for bone and soft tissue sarcoma

1 reference

12 December 2020

Recent advances in the chemotherapy of metastatic osteogenic sarcoma

1 reference

12 December 2020

Adjuvant chemotherapy of osteosarcoma: no runs, no hits, two men left on base

1 reference

12 December 2020

Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-14210), and vincristine (NSC-67574) in the treatment of osteogenic sarcoma

1 reference

12 December 2020

Amputation and Adriamycin in Primary Osteosarcoma

1 reference

12 December 2020

Cyclophosphamide in children with cancer

1 reference

12 December 2020

Clinical trials with adriamycin

1 reference

12 December 2020

Osteogenic sarcoma; a study based on 133 patients

1 reference

12 December 2020

Elective whole lung irradiation in the treatment of osteogenic sarcoma

1 reference

12 December 2020

Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study

1 reference

12 December 2020

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

1 reference

12 December 2020

A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma

1 reference

12 December 2020

Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma

1 reference

12 December 2020

Adjuvant chemotherapy in nonmetastatic osteosarcoma: a Southwest Oncology Group Study

1 reference

12 December 2020

Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn't?

1 reference

12 December 2020

Phase I and preliminary phase II evaluation of adriamycin (NSC 123127)

1 reference

12 December 2020

The therapy of osteosarcoma by intraarterial cis-platinum an limb preservation

1 reference

12 December 2020

Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk

1 reference

12 December 2020

Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies

1 reference

12 December 2020

time dependency of prognostic factors in patients with stage II osteosarcomas

1 reference

12 December 2020

L-PHENYLALANINE MUSTARD AS A TREATMENT FOR METASTATIC OSTEOGENIC SARCOMA IN CHILDREN

1 reference

12 December 2020

The changing radiographic appearance of osteogenic sarcoma

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/203531

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

23781130

1 reference